4-Amino-2-(methoxymethyl)pyrimidine-5-carbaldehyde | 76574-52-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪类
• 英文名称: 4-Amino-2-(methoxymethyl)pyrimidine-5-carbaldehyde
• 英文别名: 4-amino-2-(methoxymethyl)pyrimidine-5-carbaldehyde
• CAS: 76574-52-2
• 化学式: C₇H₉N₃O₂
• 分子量: 167.167
• InChiKey: KDLRCHQPMUPDML-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.4
• 重原子数：
  12
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  78.1
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  2,6-二氯苯乙腈 、 4-Amino-2-(methoxymethyl)pyrimidine-5-carbaldehyde 在 sodium ethanolate 作用下， 以 乙醇 为溶剂， 反应 1.0h， 以13%的产率得到6-(2,6-Dichlorophenyl)-2-(methoxymethyl)pyrido[2,3-d]pyrimidin-7-amine
  参考文献：
  名称：

  Antihypertensive activity of 6-arylpyrido[2,3-d]pyrimidin-7-amine derivatives

  摘要：

  A series of 51 6-arylpyrido[2,3-d]pyrimidin-7-amine derivatives was prepared and evaluated for antihypertensive activity in the conscious spontaneously hypertensive rat. A number of these compounds, notably 6-(2,6-dichlorophenyl)-2-methylpyrido[2,3-d]pyrimidin-7-amine (36), lowered blood pressure in these rats in a gradual and sustained manner to normotensive levels at oral doses of 10-50 mg/kg. Normalized blood pressure levels could then be maintained by single daily oral doses. The effect of structural variation in the 6-aryl group and in the 2 and 4 positions of the pyridopyrimidine ring on activity is reported and discussed.

  DOI：

  10.1021/jm00136a006
• 作为产物：
  描述：

  4-amino-2-(methoxymethyl)-5-pyrimidinecarbonitrile 在 镍 甲酸 、 氢气 作用下， 反应 3.0h， 生成 4-Amino-2-(methoxymethyl)pyrimidine-5-carbaldehyde
  参考文献：
  名称：

  Antihypertensive activity of 6-arylpyrido[2,3-d]pyrimidin-7-amine derivatives

  摘要：

  A series of 51 6-arylpyrido[2,3-d]pyrimidin-7-amine derivatives was prepared and evaluated for antihypertensive activity in the conscious spontaneously hypertensive rat. A number of these compounds, notably 6-(2,6-dichlorophenyl)-2-methylpyrido[2,3-d]pyrimidin-7-amine (36), lowered blood pressure in these rats in a gradual and sustained manner to normotensive levels at oral doses of 10-50 mg/kg. Normalized blood pressure levels could then be maintained by single daily oral doses. The effect of structural variation in the 6-aryl group and in the 2 and 4 positions of the pyridopyrimidine ring on activity is reported and discussed.

  DOI：

  10.1021/jm00136a006